Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2015 - 2026)

Perspective Therapeutics has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $64.9 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments rose 30.18% year-over-year to $64.9 million; the TTM figure through Jun 2026 stood at $214.9 million (up 91.85% YoY), while the FY2025 annual figure was $174.0 million, up 120.95% from the prior year.
• Change in Acquisitions & Divestments came in at $64.9 million for Q2 2026 at Perspective Therapeutics, up from $47.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $64.9 million in Q2 2026 to a low of -$12.5 million in Q2 2022.
• Average Change in Acquisitions & Divestments over 5 years is $35.3 million, with a median of $40.5 million recorded in 2024.
• The largest YoY upside for Change in Acquisitions & Divestments was 119.5% in 2026 against a maximum downside of 30.18% in 2026.
• Over 5 years, Change in Acquisitions & Divestments stood at $12.5 million in 2022, then jumped by 81.56% to $22.8 million in 2023, then jumped by 77.93% to $40.5 million in 2024, then jumped by 34.0% to $54.3 million in 2025, then increased by 19.48% to $64.9 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $64.9 million in Q2 2026, $47.6 million in Q1 2026, and $54.3 million in Q4 2025.